PD-1-cis IL-2R agonism yields better effectors from stem-like CD8(+) T cells

Expansion and differentiation of antigen-experienced PD-1(+)TCF-1(+) stem-like CD8(+) T cells into effector cells is critical for the success of immunotherapies based on PD-1 blockade(1–4). Hashimoto et al. have shown that, in chronic infections, administration of the cytokine interleukin (IL)-2 tri...

Descripción completa

Detalles Bibliográficos
Autores principales: Codarri Deak, Laura, Nicolini, Valeria, Hashimoto, Masao, Karagianni, Maria, Schwalie, Petra C., Lauener, Laura, Varypataki, Eleni Maria, Richard, Marine, Bommer, Esther, Sam, Johannes, Joller, Stefanie, Perro, Mario, Cremasco, Floriana, Kunz, Leo, Yanguez, Emilio, Hüsser, Tamara, Schlenker, Ramona, Mariani, Marisa, Tosevski, Vinko, Herter, Sylvia, Bacac, Marina, Waldhauer, Inja, Colombetti, Sara, Gueripel, Xavier, Wullschleger, Stephan, Tichet, Melanie, Hanahan, Douglas, Kissick, Haydn T., Leclair, Stephane, Freimoser-Grundschober, Anne, Seeber, Stefan, Teichgräber, Volker, Ahmed, Rafi, Klein, Christian, Umaña, Pablo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534752/
https://www.ncbi.nlm.nih.gov/pubmed/36171284
http://dx.doi.org/10.1038/s41586-022-05192-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534752/
https://www.ncbi.nlm.nih.gov/pubmed/36171284
http://dx.doi.org/10.1038/s41586-022-05192-0

Ejemplares similares